Clinical Trial
Published on 16 Feb 2023
The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
in Inflammation Pharmacology
- 4,831 views
- 4 citations
Clinical Trial
Published on 16 Feb 2023
in Inflammation Pharmacology
Original Research
Published on 13 Jan 2025
in Systems Immunology
Original Research
Published on 10 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 09 Apr 2015
in Plant Physiology
Original Research
Published on 24 Sep 2019
in Conservation and Restoration Ecology
Systematic Review
Published on 02 Feb 2021
in Neonatology
Original Research
Published on 16 Nov 2021
in Surgical Oncology
Original Research
Published on 12 Nov 2020
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 30 May 2023
in Cardiac Rhythmology